MARCY L'ETOILE, France--(BUSINESS WIRE)--
Regulatory News:
A world leader in the field of in vitro diagnostics, bioMérieux (Paris:BIM) confirms its constant commitment to the fight against AIDS with the launch of VIKIA® HIV 1 / 2, a rapid test for the detection of HIV infection in human serum, plasma or whole and capillary blood.
